HomeDSGN • NASDAQ
add
Design Therapeutics Inc
Previous close
$6.97
Day range
$6.58 - $7.06
Year range
$2.62 - $7.77
Market cap
380.41M USD
Avg Volume
208.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.88M | 47.75% |
Net income | -19.08M | -61.82% |
Net profit margin | — | — |
Earnings per share | -0.34 | -61.90% |
EBITDA | -21.42M | -43.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 216.28M | -17.14% |
Total assets | 222.89M | -17.32% |
Total liabilities | 9.85M | 18.09% |
Total equity | 213.04M | — |
Shares outstanding | 56.95M | — |
Price to book | 1.86 | — |
Return on assets | -23.43% | — |
Return on capital | -24.23% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -19.08M | -61.82% |
Cash from operations | -14.44M | -28.25% |
Cash from investing | 20.12M | -26.40% |
Cash from financing | 361.00K | 57.64% |
Net change in cash | 6.04M | -62.97% |
Free cash flow | -8.49M | -13.82% |
About
Founded
2017
Headquarters
Website
Employees
57
